Brian Issell, MD
Brian Issell, MD, a medical oncologist with over 40 years of experience, was the inaugural director of University of Hawaii Cancer Center, a NCI-designated cancer center. Dr. Issell has pioneered the use of IL-2 and cisplatin in oncology and has made transformative contributions in the field of medical oncology.
His activities and experiences include academic medical oncologist, academic executive, researcher and corporate executive. Dr. Issell has authored over 64 published chapters, articles and abstracts and is most recognized for his work in cancer therapeutics.
Dr. Issell is an Emeritus Director of University of Hawaii Cancer Center and professor at John A Burns School of Medicine.
Dr. Issell received his undergraduate training at University of Otago, Dunedin, New Zealand where he was also awarded his MD degree. Dr. Issell received his medical training at the University of Otago Hospital and subsequently did a medical oncology fellowship at MD Anderson Cancer Center.
Jeffrey L. Berenberg, MD
Jeffrey L. Berenberg, MD, a medical oncologist with over 40 years of clinical experience, has had many leadership roles in Hawai‘i’s community-based clinical cancer research enterprise that have been critical to the success of Hawai‘i’s long standing NCI sponsored research bases.
His activities and experiences include academic and military medical oncologist and academic executive. Dr. Berenberg has authored over 50 published chapters, articles and abstracts and is most recognized for his work on health disparity.
Currently, Dr. Berenberg is Professor of Medicine at University of Hawaii Cancer Center and Chief of Medical Oncology at John A. Burns School of Medicine (JABSOM). He has had leadership roles in Hawai‘i’s cancer clinical trials activities since 1983 and is currently principal investigator of the UHCC’s Minority-Underserved NCORP. In addition, Dr. Berenberg serves on the NCTN Colon Cancer Taskforce.
Dr. Berenberg received his undergraduate training at Harvard College and was awarded his MD degree from Boston University School of Medicine. Dr. Berenberg received his medical training at Brigham Hospital and subsequently completed a medical oncology fellowship at Walter Reed Army Medical Center.
Jeffrey Huang, PharmD
Jeffrey Huang, PharmD, a clinical pharmacologist, has strong ties with the FDA and Hawaii Medical Community.
His activities and experiences include oncology clinical pharmacology and academic medicine. Dr. Huang has worked as a clinical pharmacology reviewer for the FDA and has extensive experience in regulatory reporting to the FDA.
Currently, Dr. Huang is Assistant Professor of Medicine at University of Hawaii Cancer Center. He has had a leadership role in developing clinical trials for Hawaii Cancer Consortium.
Dr. Huang received his undergraduate training at Carleton College and was awarded his PharmD degree from University of Michigan College of Pharmacy. Dr. Huang went on to complete a Fellowship in Drug Development and Clinical Research at University of North Carolina.